Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.
Menheniott TR, O'Connor L, Chionh YT, Däbritz J, Scurr M, Rollo BN, Ng GZ, Jacobs S, Catubig A, Kurklu B, Mercer S, Minamoto T, Ong DE, Ferrero RL, Fox JG, Wang TC, Sutton P, Judd LM, Giraud AS.
Menheniott TR, et al. Among authors: minamoto t.
J Clin Invest. 2016 Apr 1;126(4):1383-400. doi: 10.1172/JCI82655. Epub 2016 Mar 14.
J Clin Invest. 2016.
PMID: 26974160
Free PMC article.